Regulation and Products


In 2009, we won a hard-fought campaign that led to Congress passing a law granting the U.S. Food and Drug Administration (FDA) the authority to regulate all tobacco products, including cigarettes, e-cigarettes, cigars and hookah. Yet, it took the FDA seven years to begin their oversight of many of these products with much more work left to be done. 

Recent spikes in the use of e-cigarettes makes clear that more must be done to regulate tobacco products and the industry's deceptive marketing practices.  We are working to ensure the government fully leverages the regulatory power it now possesses to protect children and adults. 

Tobacco use costs our nation nearly $300 billion in health care and productivity losses each year.

Take Action

Big Win Against Big Tobacco

It's time to end the youth e-cigarette vaping epidemic

We need Congress to choose kids and families over Big Tobacco and the e-cigarette industry.

Latest Updates

Cancer Candor Blog
October 2, 2020

Today’s blog is one of a series of posts highlighting how ACS CAN is examining, prioritizing and pursuing policy interventions that ensure everyone has an equal opportunity to prevent, find, treat and survive cancer. Achieving health equity in communities nationwide is a cornerstone of our mission.

September 9, 2020

Today, September 9, is the court-ordered deadline for manufacturers of e-cigarettes and certain other tobacco products to apply to the U.S. Food and Drug Administration to keep their products on the market.

August 21, 2020

WASHINGTON, D.C. – U.S. Department of Health and Human Services (HHS) announced their decision Wednesday to rescind all guidance related to U.S. Food and Drug Administration (FDA) oversight of laboratory developed tests (LDTs), a move that could have broad, negative health consequences. The following is a statement from Lisa Lacasse,

August 10, 2020

As manufacturers of e-cigarettes and certain other tobacco products face a September 9, 2020, deadline to apply to the U.S. Food and Drug Administration to keep their products on the market, six leading public health and medical organizations today urged the FDA not to authorize the sale of any flavored product

Regulation and Products Resources

Flavors are a marketing weapon the tobacco manufacturers use to target youth and young people to a lifetime of addiction. The use of any flavored tobacco product among youth is concerning because it exposes them to a lifetime of nicotine addiction, disease, and premature death.

The U.S. Secretary of HHS, U.S. Surgeon General, and Commissioner of the FDA have all declared youth e-cigarette use to be an epidemic. E-cigarette use among high school students has risen by 78 percent in the last year and 48 percent among middle school students. Furthermore, e-cigarette use is most common among younger adults – not older adults. Action is needed to reverse these trends.

Our organizations are writing in connection with the April 30 action by the U.S. Food and Drug Administration (FDA) issuing a marketing order to Philip Morris International (PMI) and Philip Morris Products S.A. allowing the U.S. marketing of IQOS heated tobacco products, to be distributed in the U.S. exclusively by Altria Client Services LLC (Altria).